The microscopic anatomy of experimental rat CC531 colon tumour metastases: Consequences for immunotherapy?

Authors: Hagenaars, Martin1; Ensink, N.2; Basse, Per3; Hokland, M.4; Nannmark, U.5; Eggermont, Alexander6; van de Velde, Cornelis2; Fleuren, Gert7; Kuppen, Peter2

Source: Clinical and Experimental Metastasis, Volume 18, Number 2, March 2000 , pp. 189-196(8)

Publisher: Springer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

The colon adenocarcinoma cell line CC531 was adopted as a model for immunotherapeutical treatment of experimental colorectal metastases in a syngeneic rat model. We studied the presence and localization of T and natural killer cells, vessels and matrix proteins in in vivo growing CC531 tumours by immunohistochemistry. CC531 tumours were induced either in the lungs by injecting CC531 tumour cells into a tail vein or in the liver by injection of CC531 tumour cells under the liver capsule or into a mesenteric vein. All 3 tumour types were composed of islets of tightly apposed tumour cells surrounded by abundantly present tumour-stroma which contained tumour vessels and matrix proteins. Some of these matrix proteins, especially laminin and collagen IV formed a basal membrane-like structure around the tumour nodules. This structure was most pronounced in mesenteric vein-induced liver tumours and less prominent in subcapsular-induced liver tumours and tail vein-induced lung tumours. Tumour-infiltrating lymphocytes of both T and natural killer cell origin were found in the tumours, but predominantly in the tumour stroma, separated from the islets of tumour cells by the basal membrane-like structure. We hypothesize that the matrix proteins of these tumours play an ambivalent role: they may provide a substratum for migration of effector cells into the tumour stroma but may also provide a barrier preventing direct contact between tumour target cells and immune effector cells.

Keywords: colon cancer; immunotherapy; matrix proteins; metastasis; rat

Document Type: Research article

DOI: 10.1023/A:1006774602360

Affiliations: 1: Departments of Surgery and Pathology, 011011011011011011011011Leiden University Medical Center, Leiden, 011011011011011011011011011The Netherlands, 2: Department of Surgery, 011011011011011011011011Leiden University Medical Center, Leiden, 011011011011011011011011011The Netherlands, 3: University of Pittsburgh Cancer Institute, Pittsburgh, 011011011011011011011011011Pennsylvania, 011011011011011011011011011USA, 4: Department of Medical Microbiology & Immunology, 011011011011011011011011University of Århus, Denmark, 5: Department of Anatomy and Cell Biology, 011011011011011011011011University of Göteborg, Sweden, 6: Department of Surgery, 011011011011011011011011University Hospital Rotterdam-Daniel den Hoed Cancer Center, Rotterdam, 011011011011011011011011011The Netherlands, 7: Pathology, 011011011011011011011011Leiden University Medical Center, Leiden, 011011011011011011011011011The Netherlands,

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A